TY - JOUR
T1 - Coronavirus and Homo Sapiens
AU - Natarajan, Pooja
AU - Kanchi, Muralidhar
AU - Gunaseelan, Vikneswaran
AU - Sigamani, Alben
AU - Harmon, James
AU - Belani, Kumar
N1 - Publisher Copyright:
© 2020 Georg Thieme Verlag. All rights reserved.
PY - 2020
Y1 - 2020
N2 - The Spanish influenza pandemic of 1918 globally claimed death between 50 and 100 million lives. In India, it was referred to as The Bombay Fever, and accounted for a fifth of the global death toll at that time. The current outbreak of the novel coronavirus disease 2019 (COVID-19), a new human-infecting beta coronavirus, has demonstrated that the size of an organism does not reflect on its ability to affect almost an entire human population. COVID-19, first detected in December 2019 in Wuhan, China, that spread rapidly worldwide. In humans, this disease ranged from flu-like symptoms to severe acute hypoxic respiratory failure. By appearance, this virus closely related to two bat-derived severe acute respiratory syndrome (SARS) coronaviruses. Although bats were likely the original host, animals sold at the Huanan seafood market in Wuhan might have been the intermediate host that enabled the emergence of the virus in humans. Under the electron microscope, the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus grips its receptor tighter than the virus behind the SARS outbreak in 2003 to 2004. The viral particle docks onto the angiotensin-converting enzyme 2 (ACE2) receptor and initiates viral entry. This review discusses the various aspects of the SARS-CoV-2 virus, its structure, pathophysiology, mechanism of interaction with human cells, virulence factors, and drug involved in the treatment of the disease.
AB - The Spanish influenza pandemic of 1918 globally claimed death between 50 and 100 million lives. In India, it was referred to as The Bombay Fever, and accounted for a fifth of the global death toll at that time. The current outbreak of the novel coronavirus disease 2019 (COVID-19), a new human-infecting beta coronavirus, has demonstrated that the size of an organism does not reflect on its ability to affect almost an entire human population. COVID-19, first detected in December 2019 in Wuhan, China, that spread rapidly worldwide. In humans, this disease ranged from flu-like symptoms to severe acute hypoxic respiratory failure. By appearance, this virus closely related to two bat-derived severe acute respiratory syndrome (SARS) coronaviruses. Although bats were likely the original host, animals sold at the Huanan seafood market in Wuhan might have been the intermediate host that enabled the emergence of the virus in humans. Under the electron microscope, the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus grips its receptor tighter than the virus behind the SARS outbreak in 2003 to 2004. The viral particle docks onto the angiotensin-converting enzyme 2 (ACE2) receptor and initiates viral entry. This review discusses the various aspects of the SARS-CoV-2 virus, its structure, pathophysiology, mechanism of interaction with human cells, virulence factors, and drug involved in the treatment of the disease.
KW - antiviral treatment
KW - corona virus spike protein
KW - cytokine storm
UR - http://www.scopus.com/inward/record.url?scp=85209464072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85209464072&partnerID=8YFLogxK
U2 - 10.1055/s-0040-1716634
DO - 10.1055/s-0040-1716634
M3 - Review article
AN - SCOPUS:85209464072
SN - 2456-9224
JO - Journal of Cardiac Critical Care
JF - Journal of Cardiac Critical Care
ER -